Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
…, S Guo, S Zhang, T Kobayashi, JA Schoonmaker… - Nature, 2010 - nature.com
Mesenchymal cells contribute to the ‘stroma’ of most normal and malignant tissues, with
specific mesenchymal cells participating in the regulatory niches of stem cells. By examining …
specific mesenchymal cells participating in the regulatory niches of stem cells. By examining …
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease
…, W Xie, D Chauhan, JA Schoonmaker… - Proceedings of the …, 2010 - National Acad Sciences
Understanding the pathogenesis of cancer-related bone disease is crucial to the discovery
of new therapies. Here we identify activin A, a TGF-β family member, as a therapeutically …
of new therapies. Here we identify activin A, a TGF-β family member, as a therapeutically …
[HTML][HTML] Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice
S Mukherjee, N Raje, JA Schoonmaker… - The Journal of …, 2008 - Am Soc Clin Investig
Drug targeting of adult stem cells has been proposed as a strategy for regenerative medicine,
but very few drugs are known to target stem cell populations in vivo. Mesenchymal stem/…
but very few drugs are known to target stem cell populations in vivo. Mesenchymal stem/…
A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genes
…, S Hussain, E Lovria, D Cheng, JA Schoonmaker… - Clinical Cancer …, 2010 - AACR
Purpose: The incidence of bone metastasis in advanced breast cancer (BrCa) exceeds 70%.
Bortezomib, a proteasome inhibitor used for the treatment of multiple myeloma, also …
Bortezomib, a proteasome inhibitor used for the treatment of multiple myeloma, also …
[PDF][PDF] The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification
…, S Stoykova, S Mukherjee, JA Schoonmaker… - Developmental cell, 2011 - cell.com
WTX is an X-linked tumor suppressor targeted by somatic mutations in Wilms tumor, a pediatric
kidney cancer, and by germline inactivation in osteopathia striata with cranial sclerosis, a …
kidney cancer, and by germline inactivation in osteopathia striata with cranial sclerosis, a …
Natural language processing for automated annotation of medication mentions in primary care visit conversations
…, KL Bonasia, JC Finora, JA Schoonmaker… - JAMIA …, 2021 - academic.oup.com
Objectives The objective of this study is to build and evaluate a natural language processing
approach to identify medication mentions in primary care visit conversations between …
approach to identify medication mentions in primary care visit conversations between …
[HTML][HTML] An audio personal health library of clinic visit recordings for patients and their caregivers (HealthPAL): user-centered design approach
…, KL Bonasia, JC Finora, JA Schoonmaker… - Journal of Medical …, 2021 - jmir.org
Background Providing digital recordings of clinic visits to patients has emerged as a strategy
to promote patient and family engagement in care. With advances in natural language …
to promote patient and family engagement in care. With advances in natural language …
High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties
…, H Ikeda, Y Okawa, T Kiziltepe, J Schoonmaker… - Clinical Cancer …, 2009 - AACR
Purpose: The increasing incidence of osteonecrosis of the jaw and its possible association
with high cumulative doses of bisphosphonate led us to study the effects of high doses of …
with high cumulative doses of bisphosphonate led us to study the effects of high doses of …
[HTML][HTML] Protocol: Heart sounds: a pilot randomised trial to determine the feasibility and acceptability of audio recordings to improve discharge communication for …
…, MD Dannenberg, SE Dodge, JA Schoonmaker… - Open Heart, 2019 - ncbi.nlm.nih.gov
InTroduCTIon Background and rationale Ineffective discharge communication can impact
patient safety, treatment adherence and readmission rates. 1 2 Patients with cardiovascular …
patient safety, treatment adherence and readmission rates. 1 2 Patients with cardiovascular …
Heart sounds: a pilot randomised trial to determine the feasibility and acceptability of audio recordings to improve discharge communication for cardiology inpatients …
…, MD Dannenberg, SE Dodge, JA Schoonmaker… - Open …, 2019 - openheart.bmj.com
Introduction Ineffective hospital discharge communication can significantly impact patient
understanding, safety and treatment adherence. This may be especially true for cardiology …
understanding, safety and treatment adherence. This may be especially true for cardiology …